Humana Inc: Form 10-K for the period ended Dec 31, 2019
Filed with the SEC on Feb 20, 2020 and accepted by EDGAR at Feb 20, 2020, 15:38 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2019-10-01 to 2019-12-31 | $16.30bn | us-gaap:Revenues |
| Revenue | 12 months2019-01-01 to 2019-12-31 | $64.89bn | us-gaap:Revenues |
| Selling, general and administrative | 12 months2019-01-01 to 2019-12-31 | $7.38bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2019-01-01 to 2019-12-31 | $3.19bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2019-01-01 to 2019-12-31 | $242.0m | us-gaap:InterestExpense |
| Income tax | 12 months2019-01-01 to 2019-12-31 | $763.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2019-10-01 to 2019-12-31 | $512.0m | us-gaap:NetIncomeLoss |
| Net income | 12 months2019-01-01 to 2019-12-31 | $2.71bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2019-10-01 to 2019-12-31 | $3.84 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2019-01-01 to 2019-12-31 | $20.10 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2019-10-01 to 2019-12-31 | $3.87 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2019-01-01 to 2019-12-31 | $20.20 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2019-01-01 to 2019-12-31 | 134,727,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2019-01-01 to 2019-12-31 | $5.28bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2019-01-01 to 2019-12-31 | $736.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2019-01-01 to 2019-12-31 | $291.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 12 months2019-01-01 to 2019-12-31 | $1.07bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2019-12-31 | $4.05bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-12-31 | $19.89bn | us-gaap:AssetsCurrent |
| Total assets | At period end2019-12-31 | $29.07bn | us-gaap:Assets |
| Current liabilities | At period end2019-12-31 | $10.93bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2019-12-31 | $17.04bn | us-gaap:Liabilities |
| Long-term debt | At period end2019-12-31 | $4.97bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2019-12-31 | $699.0m | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2019-12-31 | $12.04bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000049071-20-000032. Last ingested by Listed: Nov 10, 2026, 02:47 ET. Listed shows no prices and gives no investment advice.